Promotional review (MLR) comments for pharma content compliance AI

What a usable MLR review record contains

A usable record ties every reviewer comment to an exact span in a specific draft version and to the outcome of that comment. Most sponsors run review in a promotional review system (Veeva PromoMats, Aprimo and similar tools), where annotations live as PDF comment objects with page coordinates, reviewer role and timestamp. Export those as structured rows, not flattened PDFs, or you lose the anchor between "add fair balance here" and the sentence it targets.

The core joins are piece to version, version to annotation, annotation to claim, claim to reference and anchor, and piece to final status. Approval status alone (approved, approved with changes, revise and resubmit, rejected) supports classification. Span-level comments with before and after text support span detection and critique generation, which is where vendor value sits.

Labels come from the regulation and the review team's own taxonomy. Prescription drug advertisements that make claims must present a fair balance of benefit and risk information in both content and presentation under 21 CFR 202.1(e)(5)(ii) [1]. Useful comment categories therefore include fair balance, omission or minimization of risk, overstatement of efficacy, unsupported comparative claim, off-label implication, missing ISI or prescribing information link, and reference-anchor mismatch.

Illustrative example: invented to show structure; it does not describe an available dataset.

How promotional submissions frame the labels

FDA submission records give you an objective milestone that separates internal drafts from final, disseminated material. Promotional labeling and advertising for prescription drugs is submitted to FDA on Form 2253 (to the Office of Prescription Drug Promotion for CDER products; CBER-regulated biologics go to CBER's advertising and promotional labeling staff), and since June 24, 2021, submissions within section 745A(a) must be electronic in eCTD format [2]. A 2253 submission carries the form, the current prescribing information and the materials themselves [2].

For a dataset, the 2253 package marks the version that went out, and accelerated-approval presubmissions mark pieces reviewed under tighter scrutiny. Ask whether the supplier can link MLR job IDs to eCTD sequence numbers, because that join lets you weight final-approved text as the positive class. Untitled letters or warning letters, where a sponsor has them, are rare but high-value negative labels.

Scope matters. Over-the-counter drug advertising and medical device promotion sit under different rules and, in some cases, different regulators, so a mixed corpus can teach a model contradictory standards. Specify product type, jurisdiction (US-only versus ex-US affiliates) and audience (HCP versus consumer) up front.

Why buyers want reviewer comments now

Demand is driven by review volume and cycle time, both of which vendors and consultancies describe as constraints. One vendor reports roughly 29 business days for a piece to clear MLR, attributing delays to inconsistent reviews, changing rules and version tracking [3]. IQVIA notes that generative AI multiplies content variants, formats and derivatives, which raises review load rather than reducing it [4].

These are market observations, not benchmarks. What they imply for data is clear: the target model is a pre-reviewer that flags likely comments before a human sees the piece, and a claim checker that verifies each claim against its cited anchor. Both need disagreement data, meaning the comments reviewers actually wrote, not synthetic critiques.

Reviewer comments map naturally to critique and revision formats. A draft span, the comment and the accepted revision form a rejected-versus-chosen pair; see critique and revision data for generative verifiers and compliance-reviewed communications as alignment data for training patterns.

Rights and confidentiality checks before licensing

The draft, the comments and the reference library have three different rights holders and must be cleared separately. Drafts and comments belong to the sponsor and its agencies, and unreleased brand strategy is highly confidential. Agency-authored copy may carry its own contract terms, so ask who owns work product.

Reference articles are the trap. Clinical papers, label excerpts and congress posters attached as substantiation are usually third-party copyrighted works licensed for internal use, not redistribution. Courts have treated curated legal headnotes as copyrightable and found a non-generative training use was not fair use [5], and the Copyright Office's report, still a pre-publication version as of October 2026, concludes many acts in AI training implicate copyright owners' rights [6]. Ask for reference metadata (DOI, page, table, anchor text snippet within fair limits) rather than full PDFs, and license full text separately; see licensing legal content for AI for a parallel case.

If you are a content-compliance vendor, do not assume customer data in your own platform is trainable. The FTC has warned that model-as-a-service companies may face liability if they use customer data for undisclosed purposes such as training [8]. Licensed third-party data with documented sponsor approval avoids that conflict.

Patient content needs separate handling. Testimonials, case studies and adverse event mentions in comments can contain health information, and data from a covered entity must meet HIPAA de-identification under Safe Harbor or Expert Determination [7]. Our guide to reviewing a HIPAA Expert Determination report covers what to check.

Buyer request checklist

A precise request names the fields, scope and labels you need, so suppliers can say quickly whether their records fit.

Illustrative example: invented to show structure; it does not describe an available dataset.

• Scope: Rx small molecule and biologics; US only; HCP and DTC; exclude devices and OTC.
• Units: Pieces with at least two review rounds and a final status.
• Required fields: Version history, span-anchored comments, reviewer role, comment category, accepted revision text, claim-reference links with page anchors, final status, 2253 submission flag.
• References: Metadata and anchors only; full text excluded unless separately licensed.
• Redaction: Reviewer names and emails replaced with role tokens; brand and product names kept or masked per sponsor decision, recorded in the data card.
• Quality checks: Percentage of comments with resolvable anchors, inter-reviewer disagreement rate, share of pieces with complete version chains.
• Allowed uses: Training, evaluation, or both; whether model outputs may be shown to other sponsors.
• Holdout: A held-out brand or therapeutic area for evaluation, to measure generalization rather than memorized brand voice.

Common failure modes: comments exported without coordinates, version chains broken by re-uploads, reviewer shorthand ("see prior", "per label") with no referent, and therapeutic-area skew that teaches a model one brand's house style. Treat brand masking carefully, since masking product names can remove the very context a claim checker needs.

How this differs from other review-comment data

MLR comments are regulated-claims critique, which separates them from engineering or legal redlines. Plan review comments and code corrections and design QA/QC markups anchor comments to codes and drawings. Contract redline datasets capture negotiation, not substantiation. For general correction data, see human feedback QA scores, and for the wider health context see healthcare buyers. The industry-specific operational data hub and the AI data hub list adjacent categories.

Where SourceX fits

SourceX sources operational datasets from US companies on request, including documents and legal workflows, and manages licensing and ongoing purchases. Nothing is held in stock and a request does not guarantee a match; every release is approved by the supplying company. Each dataset is rights-reviewed for ownership and consents, personal details are removed or replaced before delivery with the method recorded and a sample checked, and health records require HIPAA de-identification. You can describe the review records you need to SourceX.

This page is general information, not legal advice. Confirm requirements with counsel for your jurisdiction and use case.

Request MLR review data for your compliance model

Describe the drafts, comments, claim links and outcomes you need, not the companies that might hold them. SourceX looks for US businesses holding matching records, assesses data and licensing permissions, and agrees pricing and allowed uses in a license before anything is delivered. Start a buyer request.